DesaiD, MoodleyJ, NaidooD. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature.Trop Doct1995; 25: 118–23
2.
FettJD, ChristieLG, CarrawayRD. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.Mayo Clin Proc2005; 80: 1602–6
BrarSS, KhanSS, SandhuGK. Incidence, mortality, and racial differences in peripartum cardiomyopathy.Am J Cardiol2007; 100: 302–4
5.
MielniczukLM, WilliamsK, DavisDR. Frequency of peripartum cardiomyopathy.Am J Cardiol2006; 97: 1765–8
6.
SliwaK, Hilfiker-KleinerD, PetrieMC. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.Eur J Heart Fail2010; 12: 767–78
7.
CooperLT, MatherPJ, AlexisJD. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women.J Card Fail2012; 18: 28–33
8.
DuranN, GunesH, DuranI. Predictors of prognosis in patients with peripartum cardiomyopathy.Int J Gynaecol Obstet2008; 101: 137–40
9.
ElkayamU, AkhterMW, SinghH. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation.Circulation2005; 111: 2050–5
10.
GolandS, BitarF, ModiK. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.J Card Fail2011; 17: 426–30
11.
GolandS, ModiK, BitarF. Clinical profile and predictors of complications in peripartum cardiomyopathy.J Card Fail2009; 15: 645–50
12.
ForsterO, Hilfiker-KleinerD, AnsariAA. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy.Eur J Heart Fail2008; 10: 861–8
13.
Hilfiker-KleinerD, KaminskiK, PodewskiE. A cathepsin D-cleaved kDa form of prolactin mediates postpartum cardiomyopathy.Cell2007; 128: 589–600
14.
SliwaK, BlauwetL, TibazarwaK. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.Circulation2010; 121: 1465–73
15.
WalentaK, SchwarzV, SchirmerSH. Circulating microparticles as indicators of peripartum cardiomyopathy.Eur Heart J2012; 33: 1469–79
MoralesA, PainterT, LiR. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.Circulation2010; 121: 2176–82
18.
Van Spaendonck-ZwartsKY, van TintelenJP, van VeldhuisenD. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy.Circulation2010; 12: 2169–75
19.
KamiyaCA, KitakazeM, Ishibashi-UedaH. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy.Circ J2011; 75: 1975–81
20.
BasakS, RudraP. Acute onset peripartum cardiomyopathy in women with severe pre-eclampsia: a diagnostic dilemma.Obstet Med, 2012 (in press)
21.
Hilfiker-KleinerD, MeyerGP, SchiefferE. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine.J Am Coll Cardiol2007; 50: 2354–5
22.
MouquetF, KaraMM, LamblinN. Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: impact of cardiac resynchronization therapy.Eur Heart J2012 (in press)
